Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin 1 receptor accessory protein-like 2 (IL1RAPL2) is a member of the interleukin 1 receptor family that shares similarity with accessory proteins in this group, especially IL1RAPL1[1][2][5]. It is encoded by the IL1RAPL2 gene, which is found on the X chromosome, and it is highly expressed in the brain, suggesting potential involvement in neuronal signaling and cognitive functions[2][3]. The protein is structurally characterized by multiple immunoglobulin domains and participates in protein-protein interactions at synapses, though its precise ligand and downstream signaling functions remain under investigation[2]. Genetic variants in the IL1RAPL2 locus have been associated with X-linked non-syndromic cognitive disability, implicating this protein in neurological development and function[1][2]. While implicated in rare diseases such as Muckle-Wells syndrome and Adult-Onset Still’s Disease, there are currently no known approved drugs directly targeting IL1RAPL2[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 1 receptor accessory protein-like 2 (IL1RAPL2).